ProFactor Pharma Ltd
C/O Ingenza Limited
Roslin Innovation Centre
Charnock Bradley Building
Roslin
Midlothian EH25 9R
Articles
- ProFactor Pharma (PFP) realise further capital injection – August 2022 September 20, 2022
- Health Tech World – Interview – Ending the Haemophilia Drug Shortage (23 November 2021) November 24, 2021
- Profactor Pharma Announces Issuance of Indian and Eurasian Patent Covering a high yielding cell line for treatment of Haemophilia A March 31, 2021
- Profactor Pharma completes optimisation of process for manufacture of lowest cost recombinant FVIII January 31, 2021
- World-wide inequalities in Haemophilia care. Things are getting better? January 19, 2021
- Outstanding technical progress July 15, 2020
- Too many Haemophilia A patients still receiving inadequate or no treatment January 26, 2020
- Paul Gerskowitch Joins PFP Board November 15, 2019
- PFP secures new investment of £2m to achieve pre-clinical trials October 30, 2019
- Press Release March 2015 – Penrose enquiry December 16, 2015